BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31561282)

  • 1. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
    Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
    Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
    Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
    Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
    Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
    Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
    van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
    Zhang Q; Zhang W; Zhang J; Xu H; You Y
    Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
    Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
    Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy.
    Kamijo T; Yokose T; Hasebe T; Yonou H; Sasaki S; Hayashi R; Ebihara S; Miyahara H; Hosoi H; Ochiai A
    Clin Cancer Res; 2000 Aug; 6(8):3159-65. PubMed ID: 10955798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High DNMT1 Is Associated With Worse Local Control in Early-Stage Laryngeal Squamous Cell Carcinoma.
    Bruine de Bruin L; Clausen MJAM; Slagter-Menkema L; de Bock GH; Langendijk JA; van der Vegt B; van der Laan BFAM; Schuuring E
    Laryngoscope; 2022 Apr; 132(4):801-805. PubMed ID: 34427325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.
    Sofocleous CT; Garg SK; Cohen P; Petre EN; Gonen M; Erinjeri JP; Downey RJ; Travis WD; Solomon SB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S676-83. PubMed ID: 23897007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of MCM2, Ki-67 and Rb protein in laryngeal squamous cell carcinomas].
    Cai K; Luo Y; Li L; Liu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 26(9):425-8. PubMed ID: 22803413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
    Rademakers SE; Hoogsteen IJ; Rijken PF; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; van der Kogel AJ; Bussink J; Kaanders JH
    Head Neck; 2015 Feb; 37(2):171-6. PubMed ID: 24347430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
    Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
    Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma.
    Li D; Dong P; Wu C; Cao P; Zhou L
    Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):705-10. PubMed ID: 24789803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.
    Lera J; Lara PC; Perez S; Cabrera JL; Santana C
    Cancer; 1998 Dec; 83(12):2493-501. PubMed ID: 9874454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Dai Y; Liu Y; Tian X; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.